Upcoming Infection Prevention conferences | Covid_19 Virus 2021 | Infection Congress Webinar Conferences | Infection Prevention 2021 Conferences | Infectious Meetings | Berlin | Switzerland | Europe | Middle East | Asia Pacific

Theme: Expanding the possibilities by infection prevention and control during Covid_19 Pandemic

Infection Prevention 2021

Infection Prevention 2021

Renowned Speakers

Marisa Egan
Saint Josephâ€™s University
USA

Shireen Samargandy
King Abdulaziz University
Saudi Arabia

Joanna Zajkowska
Medical University of Bialystok
Poland

Sarah Al-Gahtani
Al-Maarefa University of Science and Technology
Saudi Arabia

Christine I Wooddell
Arrowhead Pharmaceuticals
USA

Nichola Ashby
University of Nottingham
UK

Leena Bhattacharya Mithal
Northwestern University
USA

John P Breinholt
University of Texas McGovern Medical School
USA

Hilary Whyte
Medical Director University of Toronto
Canada

Patrick Timpel
Technische Universitaet Dresden
Germany

Cathy M Holt
University of Manchester
UK

Ricardo Munoz
Ricardo Munoz University of Pittsburgh
USA

Rizwana Popatia
Weill Cornell Medical College
USA

David A Partrick
University of Colorado
USA

Samir K Ballas
Thomas Jefferson University
USA

Alejandro Berenstein
Icahn School Of Medicine
USA

Keith J Strauss
University of Cincinnati
USA

Imran Khan
University of California
USA

Indira T Kudva
Researcher USDA
USA

Stephen Mortlock X
Liaison Quest Diagnostics
UK

Elias Tannous
Infection Control Officer Cleveland Clinic
UAE

Ashok Rattan
Pathkind Diagnostics Pvt Lt
India

Amrita Dosanjh
Rady Childrenâ€™s Hospital
USA

Ines Garcia-Garcia
University of Puerto Rico
USA

Laura Finn
Mayo Clinic
USA

Kartikeya Makker
University of Florida College of Medicine Jacksonville
USA

Sunny Po
University of Oklahoma Health Sciences Center
USA

Zharov Vladimir P
University of Arkansas for Medical Sciences
USA

Christy Cotner
California Baptist University
USA

Glenn S Tillotson
Cempra Pharmaceuticals
USA

Francis J Castellino
University of Notre Dame
USA

Issam A Mikati
Northwestern University
USA

Jason A Thompson
Emergency Products & Research, Inc.
USA

K C Santosh
University of South Dakota
USA

M Khalid Ijaz
City University of New York
USA

Shantanu Bhatt
Saint Josephâ€™s University
USA

William J Rowe
Medical University of Ohio
USA

Joshua K. Underwood
Vermont Academy
USA

Salwa Ahmed Elgebaly
Nour Heart Institute
USA

Guillermo R. Valdes
Miami Dade College BenjamÃn LeÃ³n School of Nursing
USA

Nina Gorshunova
Kursk State Medical University
Russia

Purnima-Sreenivasan
Health Aim Inc
USA

Tracey Osmond
Scalabrini Village
Australia

Eef Hogervorst
Loughborough University
UK

Yoshiro Fujii
Shin Kobe Dental Clinic
Japan

Naiara Ozamiz
University of the Basque Country
Spain

Stephen Gethin-Jones
University of Central Lancashire
UK

Siew Tzuh Tang
Chang Gung University
Taiwan

Joaquim Parra Marujo
Transpersonal Psychology and Gerontology Research Unit
Portugal

On Dulberg
Meir Medical Center
Israel

Katsuji Kobayashi
Kanazawa University
Japan

Joanna WY Chan
St. Lukeâ€™s Hospital
Singapore

Anne Cooney
Athlone Institute of Technology
Ireland

Charmaine Attard
Hilltop Gardens
Malta

Catharina Gillsjo
University of Skovde
Sweden

Gunn Tove Minde
University of Tromso
Norway

Lena Sandin-Wranker,
Lund University
San Marino

Takako Yoshimura
Kyoto Gakuen University
Japan

Elizabeth Andersen
The University of British Columbia
Canada

Huang Wei Ling
Medical Acupuncture and Pain Management Clinic
Brazil

Infection Prevention 2021

Infection Prevention welcomes all the Pathologists and Infectious Specialists throughout the world to attend Infection Prevention 2021 which will be held during June 07-08, 2021, Webinar.

Theme: Expanding the possibilities by infection prevention and control during Covid_19 Pandemic

â€‹Infection Prevention 2021 creates a platform where we gather outstanding internationally known Pathologists, Infection Prevention Conference and world-class researchers, presenters, exhibitors from premier medical universities, hospitals, companies, research centres, clinics etc., to speak on annual advancements, breakthroughs and developments in Infection Prevention , Pathology Conferences and Infectious Diseases through several sessions on keynotes, symposia, case-studies, lectures and much more.

The Conference format will feature new interactive workshop sessions for Infection Prevention and Pathology topics which will discuss new updates and management, as well as State of the Art talks on a variety of Infectious diseases in multiple subspecialties.

Infection Prevention 2021 Meeting hosts new 'Awards Nomination and Presentation' features to Speakers in appreciation to their research works towards the Global Neonatology and Perinatology advancements which include - Scientific Service Achievement Award, Research Contribution Award, Upcoming Researcher Award, Women of Science Award, Outstanding speaker, Best Keynote Speaker, Best Poster Presentation, Young Researcher Award (YRF) and so on; from Expert level to Student Level.

The themes of the webinar will include the following topics:

Infection Prevention and Control, Covid_19 Infections, Causes and symptoms of infections, SARS Coronavirus, Infection Control Procedures, Global Trends in Emerging Infections, Global Market on Infections, Infection Control in Critical Care, Emerging and Re-Emerging Infections, Epidemiology of Emerging and Re-Emerging Infections, Immunizations

Infection Prevention 2021 conference brings together an International collaboration of Scientists, Researchers, Infectious Diseases Specialists from leading universities and research institutions, company sponsors making the conference a perfect platform to share experience, foster collaboration across industry and academia, and evaluate emerging technologies across the globe.

Target Audience

Infectious Diseases Experts
Pathologists
Infectious Diseases Specialists
Pharmacists
Epidemiologists
Health Care Professionals
Microbiologists
Bacteriologists
Virologists
Parasitologists
Mycologists
Infection Prevention and Infection Control Specialists
Infection Prevention Organizations & Companies
Immunologists

Why to Attend??

Infection Prevention 2021 is giving a worldwide stage to analysts that afford new insights into the concealed methods of Infection Control and Prevention. World-eminent speakers, guest of honours, and the most up to date upgrades are particular components of this gathering and with individuals from around the globe concentrated on finding out about uncommon illnesses and its advances; An expanding number of distinguished methods makes it important to complete propelled research here of irresistible sicknesses. Infection Prevention 2021 conference is your best chance to achieve the biggest collection of members, conduct presentations, disseminate data, B2B meetings, meet with potential scientists, trade learning on late improvements and make an unmistakable imprint by invigorating development at this event.

Young Research’s Awards at Infection Prevention 2021

Infection Prevention 2021 is intended to honor prestigious award for talented Young researchers, Scientists, Young Investigators, Post-Graduate students, Post-doctoral fellows, Trainees, Junior faculty in recognition of their outstanding contribution towards the conference theme. The Young Scientist Awards make every effort in providing a strong professional development opportunity for early career academicians by meeting experts to exchange and share their experiences on all aspects of Infection Prevention and Control.

Young Research’s Awards at Infection Prevention 2021 for the Nomination:

Young Researcher Forum - Outstanding Masters/Ph.D./Post Doctorate thesis work Presentation and only 25 presentations acceptable at the Infection Prevention-2021.

YRF Registration Benefits:

Young Scientist Award recognition certificate and memento to the winners
Infection Prevention-2021 provides best Platform for your research through oral presentations.
Learn about career improvement with all the latest technologies by networking.
Provide an opportunity for research interaction and established senior investigators across the globe in the field of Infection Prevention-2021.
It’s a great privilege for young researchers to learn about the research areas for expanding their research knowledge.

YRF Registration Deadline

Till March 30 – $399
Till April 28 – $499
Till May 26 – $599

Track 1: Infection Prevention and Control

Infection care and management (IPC) may be a scientific approach and sensible answer designed to control the effect caused by infection to patients and medical examiners. One among the foremost necessary routes for transmission of infection is that the hands. Hands that infected with any contaminated item, surface or object may be contaminated with germs from that supply. The contagious transmit might deals with raw food, animals, and spattered nappies, dirty surfaces like bathrooms or hands contaminated/ infected with nasal secretion or spit when reflex, coughing or drooling. Infection hindrance associate degree management. It aims to safeguard those that could be liable to getting an infection, each within the general community and whereas receiving care thanks to health issues. Health care analysis is exposure to blood, saliva, several body fluids or aerosols which will transmit infectious materials like viral hepatitis, HIV, or different blood borne or humour microorganism. It prevents contact with probably infectious diseases by making a physical barrier between the potential infectious materials.

17^th World Congress on Infection Prevention and Control, June 07-08, 2021, Webinar; 12^th Euro-Global Conference on Infectious Diseases, October 05, 2020, Webinar; 11^th International Conference on Emerging Infectious Diseases, November 23, 2020, Webinar; 9^th International Congress on Infectious Diseases, February 07-08, 2022, London, UK; 11^th International Conference on Tropical medicine and Infectious Diseases, February 07-08, 2022, London, UK.

Relative Societies:

Europe:

USA:

Texas Society of Infection Prevention and Control, American Society of Microbiology, Canadian Society for Immunology, International AIDS Society, Infectious Diseases Society of America, National Association of Infection Prevention and Control, American Society of Infection Prevention.

Asia Pacific:

Pediatric Infectious Disease Society of Thailand, Infection Control Association, The Japanese Association for Infectious Diseases, Australasian Society for Infectious Diseases, Chinese Society for Immunology, Asia Pacific Society of Infection Control, Korean Association of Infection Disease Prevention, Korea.

Track 2: Covid_19 Infections:

The most number of affected pregnant women is increasing, but scarce information is available about the clinical features Obstetrics Infections outcomes of pregnant patients with COVID-19 in pregnancy caused by severe acute respiratory syndrome coronavirus Moreover maternal, fetal, and neonatal outcomes of patients who were infected in late pregnancy appeared very good, and these outcomes were achieved with intensive, active management that might be the best practice in the absence of more robust data. The clinical characteristics of these patients with COVID-19 during pregnancy were similar to those of non-pregnant adults with COVID-19 clinical symptoms from 33 Infections with or at risk of COVID-19 were mild and outcomes were favourable of the 3 neonates with symptomatic COVID-19, presented with early-onset SARS-CoV-2 infection. Because strict infection control and prevention procedures were implemented during the delivery, it is likely that the sources of SARS-CoV-2 in the clinical findings or investigations suggestive of COVID-19 affected to mothers, and all samples, including amniotic fluid, cord blood, and breast milk, were negative for SARS-CoV-2. The vertical maternal-fetal transmission cannot be ruled out in the current cohort. Therefore, it is crucial to screen pregnant women and implement strict infection control measures, quarantine of infected mothers, and close monitoring of at risk of COVID-19.

Relative Societies:

Europe:

USA:

Asia Pacific:

Track 3: Causes and Symptoms of Infections

Infections can be caused by bacteria, virus, fungi and parasites through direct contact, indirect contact, insect bites and food contamination. Each infectious disease has its own specific signs and symptoms. General signs and symptoms common to a number of infectious diseases include fever, diarrhoea, fatigue and muscle aches.

Relative Societies:

Europe:

USA:

Asia Pacific:

Track 4: SARS Coronavirus

Coronavirus disease (COVID-19) is an infectious disease caused by a new virus that had not been previously identified in humans. The virus causes respiratory illness (like the flu) with symptoms such as a cough, fever and in more severe cases, pneumonia. The new coronavirus spreads primarily through contact with an infected person when they cough or sneeze, or through droplets of saliva or discharge from the nose. More rarely, the disease can be fatal. Older people, and people with other medical conditions (such as asthma, diabetes, or heart disease), may be more vulnerable to becoming severely ill. Coronaviruses (CoV) are a large family of viruses that cause illness ranging from the common cold to more severe diseases such as Middle East Respiratory Syndrome (MERS-CoV) and Severe Acute Respiratory Syndrome (SARS-CoV). A novel coronavirus (nCoV) is a new strain that has not been previously identified in humans. Coronaviruses are zoonotic; they are transmitted between animals and people. Detailed investigations found that SARS-CoV was transmitted from civet cats to humans and MERS-CoV from dromedary camels to humans. Several known coronaviruses are circulating in animals that have not yet infected humans. In the past two weeks, the number of cases of COVID-19 outside China has increased 13-fold, and the number of affected countries has tripled. There are now more than 118,000 cases in 114 countries and 4,291 people have lost their lives. Thousands more are fighting for their lives in hospitals. In the days and weeks ahead, we expect to see the number of cases, the number of deaths, and the numbers of affected countries climb even higher.

Symptoms & Precautions:

Common signs of infection include respiratory symptoms, fever, and cough, shortness of breath and breathing difficulties. In more severe cases, infection can cause pneumonia, severe acute respiratory syndrome, kidney failure and even death. Standard recommendations to prevent infection spread include regular hand washing, covering mouth and nose when coughing and sneezing, thoroughly cooking meat and eggs. Avoid close contact with anyone showing symptoms of respiratory illness such as coughing and sneezing

Relative Societies:

Europe:

USA:

Asia Pacific:

Track 5: Infection Control Procedures

Infection control deals with procedures and activities which bring to prevent or reduce the risk of transmission of infectious diseases. It is mainly works in a clinical setting or working in certain laboratories are at risk of occupational exposure to blood borne pathogens including hepatitis B (Hep B), hepatitis C (Hep C) and human immune deficiency virus (HIV) as well as occupational exposure to a range of microbiological agents. Standard analysis is the work practices needed to achieve a major level of infection control and prevention. The use of common precautions aims to reduce, and to eliminate the adequate risk of transmission of infection, particularly those caused by blood borne viruses. Microorganisms are present on hands (resident flora) or acquired during healthcare activities (transient flora). In Particular hand hygiene is to reduce the number of microorganisms on your hands, particularly transient flora which may present the greater risk for infection transmission.

Relative Societies:

Europe:

USA:

Asia Pacific:

Track 6: Global Trends in Emerging Infections

An infection whose occurrence has increased in the past years or threatens to increase is termed as emerging. These diseases include new infections, previously unrecognized infections and old infections reappearing due to antimicrobial resistance, public health issues and unhygienic conditions.

Relative Societies:

Europe:

USA:

Asia Pacific:

Track 7: Global Market on Infections

Global market report of infections is a complete study of current trends in the infectious diseases therapeutic and diagnostic market, industry growth drivers, advanced therapies and restraints. It provides market projections for the coming years. It includes analysis of recent developments in technology for infection diagnosis and treatment. Market reports also includes a review of micro and macro factors essential for the existing market players and new entrants along with detailed value chain analysis.

Relative Societies:

Europe:

USA:

Asia Pacific:

Track 8: Infection Control in Critical Care

Caution is very important within the medical care unit (ICU). "We generally see a lot of infections in this population due to the length of time they may be in a unit. Infections acquired in the hospitals, especially in the intensive care unit (ICU) settings, ranging between 15% and 20%, may further lead to complications in >40% in critically ill patients. The order of incidence may vary in different settings, but the most usual causes are ventilator-associated pneumonia, intravascular catheter-associated bloodstream infection, catheter-associated urinary tract infection, posttraumatic intra-abdominal infection, and surgical site infection. Designated infection control teams should supervise the process and help in collection and compilation of data. Antibiotic Stewardship Recommendations include constituting a team, close coordination between teams, audit, formulary restriction, de-escalation, optimizing dosing, active use of information technology among other measure.

Relative Societies:

Europe:

USA:

Asia Pacific:

Track 9: Emerging and Re-Emerging Infections

When disease is caused by an organism that is newly identified and not known previously to infect humans or has changed in susceptibility to an anti-infectious drug, it is commonly called an emerging infectious disease, or simply an emerging infection. The RNA viruses that cause seasonal human epidemics of influenza are highly unstable genetically and mutate frequently during replication. Mutation, or genetic drift, results in susceptibility of individuals regardless of their exposure to the viruses before drift, requiring annual antigenic modifications in seasonal influenza vaccines to ensure protection. The short incubation period, and the mild illness caused by the majority of infections, especially among school aged children, result in rapid transmission potential that leads to seasonal influenza epidemics.

Relative Societies:

Europe:

Infection Prevention Society, Healthcare Infection Society, British Society of Parasitology, Surgical Infection Society, European Society of Clinical Microbiology and Infectious Diseases, European Association of Infection Control.tious Diseases Conferences 2021 | Infectious Diseases Conferences USA | Infectious Diseases Conferences 2021 Asia

USA:

Asia Pacific:

Track 10: Epidemiology of Emerging and Re-Emerging Infections

Epidemiology studies the patterns, causes and effects of health and disease conditions. It is the cornerstone of public health and informs policy decisions and evidence based practice by identifying risk factors for disease and targets for preventive healthcare. Epidemiologists help with study design, data collection, statistical analysis of data, interpretation and dissemination. Epidemiology helped to develop methodology used in clinical research, public health studies and to a lesser extent basic research in the biological sciences.

Relative Societies:

Europe:

USA:

Asia Pacific:

Track 11: Immunizations:

Immunization is that the strategy whereby a methodology is involved in immune or proof against a disease, typically by the administration of AN immunogenic. It is one among cost-effective health investments, with verified strategies that build it accessible to even the foremost hard-to-reach and vulnerable populations. Immunizations are often stated as less risky and an appropriate way to become immune to a particular disease than risking a milder form of the disease itself. Other molecules are used for protection further, for example in experimental vaccines against nicotine (NicVAX) or the hormone ghrelin in experiments to create an obesity vaccine. They are necessary for every adult and youngsters therein they will shield themselves from the numerous diseases out there. Immunization not solely protects kids against deadly diseases but jointly helps in developing children's immune systems.

Relative Societies:

Europe:

USA:

Asia Pacific:

Infection control is an essential measure across healthcare industry in order to avoid infectious diseases. Infectious diseases are caused by pathogenic microorganisms, such as bacteria, viruses, parasites or fungi; the diseases can be spread, directly or indirectly, either from one person to another, from infected or non-sterilized surgical or medical devices used to treat a person, or from being in the infected environment of any healthcare facility. Thus, to prevent and reduce the occurrence rate of infectious diseases, various healthcare facilities are adopting infection control

COVID-19 Impact on Infection Control Market

Infection control products are one of the core parts of any healthcare facility. The current COVID-19 pandemic has changed the way markets function at both demand and supply side. From demand perspective, nearly 70-80% of the hospitals are struggling with shortage of ventilators, masks, other personal protective equipment, hospital beds, and other supplies; whereas, with disturbed supply chains and production capacity shortages, manufacturers of hospital beds and supplies are not able to meet the demand. As a result, various countries with high infection rate are currently facing huge shortfall for infection control products. The majorly impacted countries are present in developed region and thus to address this situation, government agencies in every country are focusing on alternative ways to increase the production capacity. For instance,

As of April 2020, Lamborghini has joined the companies fighting the ongoing coronavirus pandemic, producing surgical masks and protective shields. The masks and plexiglass shields will be produced in Lamborghini’s super sports car production plant in Sant’Agata Bolognese, and will be donated to the Sant’Orsola-Malpighi Hospital in Bologna. Lamborghini will work on the manufacturing of the equipment, creating 1,000 masks a day. 3D printers within the carbon fiber production plant will be used to produce 200 medical shields a day.

One of the Toronto-based Canada Emergency Medical Manufacturers (CEMM) said it has begun mobilizing a collective effort for furniture and apparel manufacturers to produce medical gowns in April 2020.

In April 2020, Munich-based premium automaker, BMW, has also entered the mask-making business.

In March 2020, Retailers Canada Goose Holdings Inc and Gap Inc announced to begin the production of scrubs and patient gowns for healthcare workers and patients to aid the battle against the coronavirus pandemic.

In March 2020, Reifenhäuser GmbH & Co. KG Maschinenfabrik (Germany) has launched a pilot production line to manufacture the mask fabric in Germany. Output has reached 1 million masks daily, even though production is still in its trial phase

The infection control market study by Meticulous Research® presents historical market data in terms of value (2018, and 2019), estimated current data (2020), and forecasts for 2027 - by product, end user, and geography. The study also evaluates industry competitors and analyzes the market at regional and country level.

Based on product type, the cleaning & disinfection products segment is estimated to account for the largest share of the overall infection control market in 2020. Rising number of healthcare associated infections (HAIs) due to the unhygienic surroundings is one of the key reasons for the largest share of this market.

North America is estimated to dominate the global infection control market in 2020, followed by Europe, and Asia Pacific. This growth in North America can be attributed to the increasing hospital & outpatient visits, rising number of surgical procedures, growing number of HAIs, increasing healthcare expenditure, growth in the pharma & biotech industry, increasing aging population with chronic diseases, and government initiatives to reduce HAIs & implement effective infection control practices. However, Asia Pacific region is expected to grow at the fastest CAGR during the forecast period. The factors driving the growth of the Asia Pacific infection control market are accelerated economic growth of many countries, growing government focus on healthcare sector, rising prevalence of infectious diseases including COVID-19, and government initiatives for boosting production of infection control products.

Conference Highlights

To share your views and research, please click here to register for the Conference.

To Collaborate Scientific Professionals around the World

Conference Date	June 07-08, 2021
Sponsors & Exhibitors	~~Click here for Sponsorship Opportunities~~
Speaker Opportunity Closed	Day 1
Poster Opportunity Closed	Click Here to View